Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
US regulators approve new type of pain drug designed to eliminate the risks of addiction associated with opioids.
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Washington — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with certain patient monitors from Contec and Epsimed and urged healthcare ...
The Food and Drug Administration (FDA) says a previously announced recall of certain bags of Lay’s potato chips in Oregon and ...